Precision will be at this year’s Gene Therapy for Rare Disorders on March 26-29, 2024, in Boston, MA. Connect with our team of experts as they lead meaningful presentations and discussions throughout this event providing insights into the clinical development, manufacturing, and commercialization for gene therapies.

Speaking Engagements
Detailed descriptions for each speaking engagement are included below. 

  • Precision will have a plenary speaking position on March 27, 2024, 8:30 – 9:00 am.
  • Precision’s Andy Kinley (VP, Innovation & Clinical Science, Precision for Medicine) will Chair the Clinical track session, “Clinical Endpoints for Rare Disease Studies,” on March 28, 2024, 11:15 am – 12:15 pm.

Connect with our Advanced Therapy experts

  • Schedule in-person or virtual meetings with our team

Plenary Speaking Position: What to Look Forward to for Gene Therapy in 2024
Precision | March 27, 2024, 8:30 – 9AM ET 

  • Key Takeaways
    • Market trends and expectations for Gene Therapies & Rare Diseases in 2024 
    • Predictions on Potential Approvals in 2024 
    • Innovative Trends & Technologies 
    • Evolution of CMC and manufacturing 


  • [Moderator] Jake Greenwood, VP, Project Farma  
  • Faraz Ali, CEO, Tenaya Therapeutics  
  • Debs Phippard, CSO, Precision for Medicine  
  • Frank Bugg, Global Head of BaseCamp Operations & Commercial, ElevateBio  

Panel Discussion: Manufacturing Track: Capacity versus Capability – Moving Towards Innovative Manufacturing Processes
Precision | March 28, 2024, 11:15AM – 12:15PM ET

  • Andy Kinley, VP, Innovation & Clinical Science (Precision for Medicine) to Chair